554 related articles for article (PubMed ID: 28786023)
21. Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells.
Yoshimura A; Asahina Y; Chang LY; Angata T; Tanaka H; Kitajima K; Sato C
J Biol Chem; 2021; 296():100477. PubMed ID: 33640457
[TBL] [Abstract][Full Text] [Related]
22. Gene conversions are frequent but not under positive selection in the Siglec gene families of primates.
Zid M; Drouin G
Genome; 2014 Jun; 57(6):317-25. PubMed ID: 25166301
[TBL] [Abstract][Full Text] [Related]
23. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
24. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
Jones C; Virji M; Crocker PR
Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans.
Naujoks W; Quandt D; Hauffe A; Kielstein H; Bähr I; Spielmann J
Front Immunol; 2020; 11():573200. PubMed ID: 33101297
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation-mediated Siglec-7 regulation in natural killer cells via two 5' promoter CpG sites.
Huang HT; Su SC; Chiou TJ; Lin YH; Shih YC; Wu YX; Fan TH; Twu YC
Immunology; 2020 May; 160(1):38-51. PubMed ID: 32027025
[TBL] [Abstract][Full Text] [Related]
27. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.
Angata T; Hayakawa T; Yamanaka M; Varki A; Nakamura M
FASEB J; 2006 Oct; 20(12):1964-73. PubMed ID: 17012248
[TBL] [Abstract][Full Text] [Related]
29. Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.
Rapoport EM; Pazynina GV; Sablina MA; Crocker PR; Bovin NV
Biochemistry (Mosc); 2006 May; 71(5):496-504. PubMed ID: 16732727
[TBL] [Abstract][Full Text] [Related]
30. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia.
Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
Blood; 2009 Oct; 114(18):3822-30. PubMed ID: 19710502
[TBL] [Abstract][Full Text] [Related]
31. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes.
Zhang JQ; Nicoll G; Jones C; Crocker PR
J Biol Chem; 2000 Jul; 275(29):22121-6. PubMed ID: 10801862
[TBL] [Abstract][Full Text] [Related]
32. Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
Benmerzoug S; Chevalier MF; Verardo M; Nguyen S; Cesson V; Schneider AK; Dartiguenave F; Rodrigues-Dias SC; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
Eur Urol Focus; 2022 May; 8(3):748-751. PubMed ID: 34147404
[TBL] [Abstract][Full Text] [Related]
33. Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.
Belisle JA; Horibata S; Jennifer GA; Petrie S; Kapur A; André S; Gabius HJ; Rancourt C; Connor J; Paulson JC; Patankar MS
Mol Cancer; 2010 May; 9():118. PubMed ID: 20497550
[TBL] [Abstract][Full Text] [Related]
34. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
Lock K; Zhang J; Lu J; Lee SH; Crocker PR
Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
[TBL] [Abstract][Full Text] [Related]
36. Impact of polysialylated CD56 on natural killer cell cytotoxicity.
Moebius JM; Widera D; Schmitz J; Kaltschmidt C; Piechaczek C
BMC Immunol; 2007 Aug; 8():13. PubMed ID: 17683591
[TBL] [Abstract][Full Text] [Related]
37. Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
Meril S; Harush O; Reboh Y; Matikhina T; Barliya T; Cohen CJ
Mol Carcinog; 2020 Jul; 59(7):713-723. PubMed ID: 32391973
[TBL] [Abstract][Full Text] [Related]
38. High-affinity ligands of Siglec receptors and their therapeutic potentials.
Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
[TBL] [Abstract][Full Text] [Related]
39. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
40. Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity.
Jacobson A; Bell F; Lejarcegui N; Mitchell C; Frenkel L; Horton H
PLoS One; 2013; 8(6):e67700. PubMed ID: 23805324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
